Introduction
Administration of RMI 12,936 (17ß-hydroxy-7a-methylandrost-5-en-3-one) on the 2nd day of dioestrus in the rat inhibited ovulation, reduced tonic LH levels in serum and blocked the prooestrous LH surge (Kendle, Paterson & Wilson, 1978) . Ovulation was restored by hCG or LH-RH but hypophysial sensitivity to LH-RH was less than when ovulation was blocked with sodium pentobarbitone. Hypothalamic dopamine levels increase to a peak value during the day of pro-oestrus (Negro-Vilar, Chiocchio & Tranezzani, 1977) and dopamine has been shown to facilitate LH release in vivo and in vitro (Schneider & McCann, 1969 , 1970 . The present study was therefore undertaken to determine whether inhibition of ovulation by RMI 12,936 could be attributed to hormone antagonism acting by modification of hypothalamic dopaminergic path¬ ways.
Materials and General Methods
General SPF-derived rats of the Sprague-Dawley strain were housed as described previously (Kendle, 1975) with artificial illumination from 08:00 to 20:00 h daily. Vaginal 
Discussion
Treatment with RMI 12,936 that inhibits ovulation also inhibits the pro-oestrous peak of hypo¬ thalamic dopamine. The anti-ovulatory effect is partly reversed by progesterone and fully reversed by oestrogen and progesterone. RMI 12,936 is known to inhibit progesterone synthesis (Kendle, 1976) , probably by acting as an alternative substrate for 5-3 ketosteroid isomerase (Taylor & Kendle, 1978) . Oestrogen synthesis also involves enzymic isomerization of 5-3 ketosteroids and is therefore likely to be inhibited by RMI 12, 936 treatment. Oestrogen is necessary for the development of the facilitatory effect of progesterone on ovulation (Brown-Grant, 1969) and for the induction of hypothalamic progesterone receptors (Kato & Onouchi, 1977; MacLuski & McEwen, 1978) . The results indicate that treatment with RMI 12,936 reduces oestrogen levels to less than the critical level for these effects in 50% of treated animals, but full sensitivity to progesterone is obtained by treatment with oestrogen.
Administration of gonadal steroids reversed the inhibition of ovulation following RMI 12,936 treatment but hypophysial sensitivity to LH-RH remained significantly lower than in animals in which ovulation was inhibited with sodium pentobarbitone. Oestrogen (Arimura & Schally, 1971; , progesterone and LH-RH (Aiyer, Chiappa & Fink, 1974) The hypothalamic dopamine peak occurs in control animals earlier than the time of progesterone administration in the steroid replacement experiments. If this peak were restored in these experiments it must therefore be an effect of oestrogen and previous work has shown that oestrogen can increase dopamine uptake in the anterior hypothalamus (Cardinali & Gomez, 1977) . The results show however that the hypothalamic dopamine peak was not restored by oestrogen treatment and that administration of L-DOPA did not restore ovulation in rats treated with RMI 12,936 although it will do so in rats in which the block is due to inhibition of catecholamine synthesis (Kordon & Glowinski, 1969) . It must therefore be concluded that dopamine has a non-essential role in the control of ovulation, possibly associated with increasing hypophysial sensitivity to LH-RH. Further investigations are being undertaken to determine whether the dopamine peak represents enhanced activity in a stimulatory pathway or reduced amine turnover in an inhibitory pathway.
Previous studies have shown that ovulation may be induced in RMI 12,936-treated rats by administration of LH-RH or hCG. This would suggest that normal follicles were present in the ovary during pro-oestrus and the present histological investigation shows this to be the case. The presence of very large follicles in treated animals on the day of oestrus confirms ovulation failure. Since the treatment is followed by a prolonged period without ovulation it is probable that these large follicles become atretic but further investigation is necessary to establish this.
